Lefamulin最初由Nabriva开发,2018年3月仑胜医药获得在大中华区,包括中国大陆、香港、澳门、台湾开...查看全文
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 425 - Prospectuses and communications, business combinations Filed: 2017-05-23 AccNo: 0001104659-17-034613 Size: 18 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ SC 14D9 - Solicitation, recommendation statements Filed: 2017-05-23 AccNo: 0001047469-17-003556 Size: 34 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ SC TO-T - Tender offer statement by Third Party Filed: 2017-05-23 AccNo: 0001047469-17-003554 Size: 1 MB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-05-16,Director,Talbot George Harrison ,卖出,150普通股, $102.76
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-05-15,Director,Talbot George Harrison ,卖出,50普通股, $101.50
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 8-K/A [Amend] - Current report Filed: 2017-05-12 AccNo: 0001104659-17-032362 Size: 216 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 8-K - Current report Filed: 2017-05-10 AccNo: 0001104659-17-031616 Size: 211 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-10 AccNo: 0001104659-17-031600 Size: 5 MB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-28,10% Owner,HBM Healthcare Investments (Ca ,卖出,15130普通股, $11.03
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-27,10% Owner,HBM Healthcare Investments (Ca ,卖出,100普通股, $11.00